BIOCRYST PHARMACEUTICALS INC (BCRX) — Institutional Holders, Q2 2026
319 institutional investment managers reported a BCRX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.6B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1 to 100. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
BCRX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- MILLENNIUM MANAGEMENTAdded · +3,207,008 sh+$32.1M
- STATE STREETAdded · +2,982,738 sh+$29.8M
- PERCEPTIVE ADVISORSAdded · +2,874,855 sh+$28.7M
- JANE STREET GROUPAdded · +2,140,076 sh+$21.4M
- GOLDMAN SACHS GROUPAdded · +2,134,431 sh+$21.3M
Biggest sellers
- Royalty Pharma Sub-ManagerSold out · -3,846,154 sh-$38.5M
- Kynam Capital ManagementTrimmed · -3,158,135 sh-$31.6M
- RFG AdvisorySold out · -2,870,700 sh-$28.7M
- SUSQUEHANNA INTERNATIONAL GROUP, LLPTrimmed · -1,619,653 sh-$16.2M
- Eversept PartnersTrimmed · -1,174,167 sh-$11.7M
BCRX 13F holders ranked 1–100 of 319
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | BlackRock#1 · 23,893,036 sh | 23,893,036 | $238.9M | <0.01% | +5.5% |
| 2 | RA CAPITAL MANAGEMENT, L.P.#2 · 15,827,186 sh | 15,827,186 | $158.3M | 1.38% | 0.0% |
| 3 | STATE STREET#3 · 15,191,098 sh | 15,191,098 | $151.9M | <0.01% | +24.4% |
| 4 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)#4 · 15,096,403 sh | 15,096,403 | $151.0M | 1.57% | +0.4% |
| 5 | VANGUARD CAPITAL MANAGEMENT#5 · 11,364,236 sh | 11,364,236 | $113.6M | <0.01% | +2.1% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT#6 · 11,139,158 sh | 11,139,158 | $111.4M | <0.01% | -0.9% |
| 7 | TCG Crossover Management#7 · 11,020,968 sh | 11,020,968 | $110.2M | 2.65% | 0.0% |
| 8 | PERCEPTIVE ADVISORS#8 · 10,308,888 sh | 10,308,888 | $103.1M | 1.55% | +38.7% |
| 9 | Jupiter Topco#9 · 9,540,764 sh | 9,540,764 | $95.3M | 0.04% | — |
| 10 | Vestal Point Capital#10 · 8,300,000 sh | 8,300,000 | $83.0M | 1.94% | +18.1% |
| 11 | TWO SIGMA INVESTMENTS#11 · 6,775,349 sh | 6,775,349 | $67.8M | 0.05% | +6.0% |
| 12 | GEODE CAPITAL MANAGEMENT#12 · 6,248,046 sh | 6,248,046 | $62.5M | <0.01% | +8.0% |
| 13 | abrdn plc#13 · 5,310,871 sh | 5,310,871 | $53.1M | 0.07% | +5.4% |
| 14 | UBS Group AG#14 · 5,078,280 sh | 5,078,280 | $50.8M | <0.01% | +2.7% |
| 15 | BANK OF AMERICA#15 · 4,801,284 sh | 4,801,284 | $48.0M | <0.01% | -5.7% |
| 16 | GOLDMAN SACHS GROUP#16 · 4,481,874 sh | 4,481,874 | $44.8M | <0.01% | +90.9% |
| 17 | Frazier Life Sciences Management, L.P.#17 · 4,009,240 sh | 4,009,240 | $40.1M | 0.87% | 0.0% |
| 18 | Nuveen#18 · 4,007,237 sh | 4,007,237 | $40.1M | <0.01% | +4.9% |
| 19 | MILLENNIUM MANAGEMENT#19 · 3,394,729 sh | 3,394,729 | $33.9M | 0.01% | +1708.4% |
| 20 | GW&K Investment Management#20 · 3,171,113 sh | 3,171,113 | $31.7M | 0.25% | -2.1% |
| 21 | JANE STREET GROUP#21 · 2,762,683 sh | 2,762,683 | $27.6M | <0.01% | +343.7% |
| 22 | DIMENSIONAL FUND ADVISORS#22 · 2,718,781 sh | 2,718,781 | $27.2M | <0.01% | +1.0% |
| 23 | Fisher Asset Management#23 · 2,604,027 sh | 2,604,027 | $26.0M | <0.01% | -4.7% |
| 24 | RENAISSANCE TECHNOLOGIES#24 · 2,530,290 sh | 2,530,290 | $25.3M | 0.03% | +225.7% |
| 25 | Kynam Capital Management#25 · 2,522,660 sh | 2,522,660 | $25.2M | 1.39% | -55.6% |
| 26 | Candriam S.C.A.#26 · 2,514,949 sh | 2,514,949 | $25.1M | 0.11% | +10.0% |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT#27 · 2,353,291 sh | 2,353,291 | $23.5M | <0.01% | +0.1% |
| 28 | RICE HALL JAMES & ASSOCIATES#28 · 2,332,043 sh | 2,332,043 | $23.3M | 1.14% | +4.6% |
| 29 | NORTHERN#29 · 2,255,731 sh | 2,255,731 | $22.6M | <0.01% | +7.2% |
| 30 | AQR CAPITAL MANAGEMENT#30 · 2,214,302 sh | 2,214,302 | $22.1M | <0.01% | +403.1% |
| 31 | MORGAN STANLEY#31 · 1,999,684 sh | 1,999,684 | $20.0M | <0.01% | -1.2% |
| 32 | Nantahala Capital Management#32 · 1,901,160 sh | 1,901,160 | $19.0M | 0.63% | -4.3% |
| 33 | Eversept Partners#33 · 1,865,653 sh | 1,865,653 | $18.7M | 0.97% | -38.6% |
| 34 | ORBIMED ADVISORS#34 · 1,852,000 sh | 1,852,000 | $18.5M | 0.34% | +29.9% |
| 35 | HEALTHCARE OF ONTARIO PENSION PLAN FUND#35 · 1,844,912 sh | 1,844,912 | $18.4M | 0.03% | +50.4% |
| 36 | STIFEL FINANCIAL#36 · 1,826,234 sh | 1,826,234 | $18.3M | 0.02% | +0.1% |
| 37 | VANGUARD FIDUCIARY#37 · 1,759,573 sh | 1,759,573 | $17.6M | <0.01% | +5.7% |
| 38 | CITADEL ADVISORS#38 · 1,759,160 sh | 1,759,160 | $17.6M | <0.01% | +72.7% |
| 39 | JUPITER ASSET MANAGEMENT LTD#39 · 1,642,874 sh | 1,642,874 | $16.4M | 0.08% | +37.3% |
| 40 | IMC-Chicago#40 · 1,634,336 sh | 1,634,336 | $16.3M | <0.01% | +158.9% |
| 41 | Parkman Healthcare Partners#41 · 1,624,279 sh | 1,624,279 | $16.2M | 1.66% | -4.9% |
| 42 | Legal & General Group Plc#42 · 1,455,514 sh | 1,455,514 | $14.6M | <0.01% | +3.1% |
| 43 | OP Asset Management Ltd#43 · 1,340,990 sh | 1,340,990 | $13.4M | 0.14% | +7.0% |
| 44 | Invesco Ltd.#44 · 1,233,783 sh | 1,233,783 | $12.3M | <0.01% | -5.7% |
| 45 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#45 · 1,195,651 sh | 1,195,651 | $12.0M | <0.01% | -57.5% |
| 46 | Pictet Asset Management Holding SA#46 · 1,249,771 sh | 1,249,771 | $12.0M | 0.01% | +165.0% |
| 47 | BNP PARIBAS FINANCIAL MARKETS#47 · 1,174,052 sh | 1,174,052 | $11.7M | <0.01% | -9.8% |
| 48 | FIRST ADVISORS#48 · 1,120,469 sh | 1,120,469 | $11.2M | <0.01% | +39.9% |
| 49 | HRT FINANCIAL#49 · 1,081,523 sh | 1,081,523 | $10.8M | 0.03% | New |
| 50 | MOORE CAPITAL MANAGEMENT#50 · 848,336 sh | 848,336 | $8.5M | 0.13% | New |
| 51 | FMR#51 · 808,903 sh | 808,903 | $8.1M | <0.01% | +27.8% |
| 52 | ExodusPoint Capital Management#52 · 744,917 sh | 744,917 | $7.4M | 0.05% | +291.9% |
| 53 | Man Group plc#53 · 732,867 sh | 732,867 | $7.3M | 0.01% | -43.3% |
| 54 | Rosalind Advisors#54 · 721,504 sh | 721,504 | $7.2M | 1.90% | -21.8% |
| 55 | Schonfeld Strategic Advisors#55 · 710,816 sh | 710,816 | $7.1M | 0.03% | -46.9% |
| 56 | Bank of New York Mellon#56 · 680,481 sh | 680,481 | $6.8M | <0.01% | +6.7% |
| 57 | Jump Financial#57 · 569,956 sh | 569,956 | $5.7M | 0.05% | +420.9% |
| 58 | DEUTSCHE BANK AG\#58 · 563,361 sh | 563,361 | $5.6M | <0.01% | -31.4% |
| 59 | VOYA INVESTMENT MANAGEMENT#59 · 538,813 sh | 538,813 | $5.4M | <0.01% | +0.5% |
| 60 | Elmind Capital#60 · 520,000 sh | 520,000 | $5.2M | 1.31% | -48.0% |
| 61 | JPMORGAN CHASE#61 · 525,449 sh | 525,449 | $5.1M | <0.01% | -65.9% |
| 62 | Bridgewater Associates#62 · 491,057 sh | 491,057 | $4.9M | 0.02% | -23.0% |
| 63 | FRANKLIN RESOURCES#63 · 480,364 sh | 480,364 | $4.8M | <0.01% | -8.2% |
| 64 | PRINCIPAL FINANCIAL GROUP#64 · 468,785 sh | 468,785 | $4.7M | <0.01% | +8.9% |
| 65 | NAN FUNG TRINITY (HK) Ltd#65 · 450,000 sh | 450,000 | $4.5M | 0.44% | New |
| 66 | SPHERA FUNDS MANAGEMENT LTD.#66 · 422,051 sh | 422,051 | $4.2M | 0.55% | -51.3% |
| 67 | Swiss National Bank#67 · 415,268 sh | 415,268 | $4.2M | <0.01% | +1.6% |
| 68 | D. E. Shaw#68 · 408,529 sh | 408,529 | $4.1M | <0.01% | +35.2% |
| 69 | Susquehanna Portfolio Strategies#69 · 404,704 sh | 404,704 | $4.0M | 0.06% | +8.2% |
| 70 | DAFNA Capital Management#70 · 400,248 sh | 400,248 | $4.0M | 0.76% | -7.0% |
| 71 | Hudson Bay Capital Management#71 · 400,000 sh | 400,000 | $4.0M | 0.01% | -18.4% |
| 72 | WEDGE CAPITAL MANAGEMENT L L P#72 · 380,801 sh | 380,801 | $3.8M | — | New |
| 73 | DOLIVER ADVISORS#73 · 374,328 sh | 374,328 | $3.7M | — | 0.0% |
| 74 | Aquatic Capital Management#74 · 362,895 sh | 362,895 | $3.6M | 0.12% | New |
| 75 | CITIGROUP#75 · 360,189 sh | 360,189 | $3.6M | <0.01% | +406.1% |
| 76 | Assenagon Asset Management S.A.#76 · 353,044 sh | 353,044 | $3.5M | — | +51.6% |
| 77 | MACKENZIE FINANCIAL#77 · 347,299 sh | 347,299 | $3.5M | <0.01% | +42.7% |
| 78 | Phocas Financial#78 · 340,541 sh | 340,541 | $3.4M | 0.47% | +74.2% |
| 79 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME#79 · 320,566 sh | 320,566 | $3.2M | <0.01% | -13.1% |
| 80 | ALPS ADVISORS#80 · 317,960 sh | 317,960 | $3.2M | 0.01% | +427.7% |
| 81 | ALLIANCEBERNSTEIN L.P.#81 · 327,909 sh | 327,909 | $3.1M | <0.01% | +24.4% |
| 82 | PRICE T ROWE ASSOCIATES#82 · 305,897 sh | 305,897 | $3.1M | <0.01% | +32.4% |
| 83 | WELLINGTON MANAGEMENT GROUP LLP#83 · 293,925 sh | 293,925 | $2.9M | <0.01% | +197.2% |
| 84 | RHUMBLINE ADVISERS#84 · 279,839 sh | 279,839 | $2.8M | <0.01% | +5.1% |
| 85 | NFJ INVESTMENT GROUP#85 · 278,792 sh | 278,792 | $2.8M | 0.09% | New |
| 86 | Rafferty Asset Management#86 · 265,618 sh | 265,618 | $2.7M | <0.01% | -25.0% |
| 87 | Point72 Asset Management, L.P.#87 · 260,917 sh | 260,917 | $2.6M | <0.01% | New |
| 88 | WINTON GROUP Ltd#88 · 255,600 sh | 255,600 | $2.6M | 0.08% | +380.3% |
| 89 | MARSHALL WACE, LLP#89 · 252,764 sh | 252,764 | $2.5M | <0.01% | +2.6% |
| 90 | MARTINGALE ASSET MANAGEMENT L P#90 · 242,508 sh | 242,508 | $2.4M | 0.06% | +329.0% |
| 91 | IEQ CAPITAL#91 · 227,421 sh | 227,421 | $2.3M | 0.01% | New |
| 92 | WELLS FARGO & COMPANY#92 · 222,894 sh | 222,894 | $2.2M | <0.01% | -5.9% |
| 93 | HUSSMAN STRATEGIC ADVISORS#93 · 210,000 sh | 210,000 | $2.1M | 0.48% | New |
| 94 | PFM Health Sciences#94 · 207,357 sh | 207,357 | $2.1M | 0.18% | New |
| 95 | VANGUARD ASSET MANAGEMENT, Ltd#95 · 196,280 sh | 196,280 | $2.0M | <0.01% | 0.0% |
| 96 | TUDOR INVESTMENT ET AL#96 · 195,128 sh | 195,128 | $2.0M | <0.01% | New |
| 97 | Engineers Gate Manager#97 · 175,002 sh | 175,002 | $1.8M | 0.02% | -10.0% |
| 98 | Squarepoint Ops#98 · 174,714 sh | 174,714 | $1.7M | <0.01% | +339.4% |
| 99 | Janney Montgomery Scott#99 · 163,267 sh | 163,267 | $1.6M | <0.01% | 0.0% |
| 100 | QTR Family Wealth#100 · 161,082 sh | 161,082 | $1.6M | 0.56% | +2.6% |
Funds that sold out of BCRX in Q2 2026 (38)
Held BCRX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.